Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28.

Article  PubMed  Google Scholar 

Zhou J, Lin Y, Yang X, Shen B, Hao J, Wang J, et al. Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress. Cell Mol Biol Lett. 2022;27(1):110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuzaki S, Klar M, Matsuzaki S, Roman LD, Sood AK, Matsuo K. Uterine carcinosarcoma: contemporary clinical summary, molecular updates, and future research opportunity. Gynecol Oncol. 2021;160(2):586–601.

Article  CAS  PubMed  Google Scholar 

Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, et al. Pembrolizumab plus chemotherapy in advanced endometrial cancer. N Engl J Med. 2023;388(23):2159–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao Y, Jin L, Deng C, Guan Y, Kalogera E, Ray U, et al. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer. Oncogene. 2021;40(8):1409–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mourksi NE, Dalban C, Colombe-Vermorel A, Odeyer L, Simioni V, Frenel JS, et al. Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group. Mol Oncol. 2023;17(1):27–36.

Article  CAS  PubMed  Google Scholar 

van den Heerik A, Horeweg N, de Boer SM, Bosse T, Creutzberg CL. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy. Int J Gynecol Cancer. 2021;31(4):594–604.

Article  PubMed  Google Scholar 

Trivedi DV, Nag S, Spudich A, Ruppel KM, Spudich JA. The myosin family of mechanoenzymes: from mechanisms to therapeutic approaches. Annu Rev Biochem. 2020;89:667–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, et al. Silencing MYH9 blocks HBx-induced GSK3beta ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5(1):13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Liu X, Lin X, Zhao M, Xiao Y, Liu C, et al. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. Signal Transduct Target Ther. 2019;4:48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Jiang Q, Liu X, Lin X, Tang Z, Liu C, et al. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3beta/beta-catenin signaling pathway. EBioMedicine. 2019;48:386–404.

Article  PubMed  PubMed Central  Google Scholar 

Engevik KA, Engevik MA, Engevik AC. Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis. PLoS ONE. 2023;18(1): e0280428.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tochimoto M, Oguri Y, Hashimura M, Konno R, Matsumoto T, Yokoi A, et al. S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma. Lab Invest. 2020;100(5):682–95.

Article  CAS  PubMed  Google Scholar 

Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40–55.

Article  CAS  PubMed  Google Scholar 

Li YK, Zeng T, Guan Y, Liu J, Liao NC, Wang MJ, et al. Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance. Int J Biol Sci. 2023;19(1):258–80.

Article  PubMed  PubMed Central  Google Scholar 

Mo J, Ruan S, Yang B, Jin Y, Liu K, Luo X, et al. A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer. J Zhejiang Univ Sci B. 2023;24(1):64–77.

Article  CAS  PubMed  Google Scholar 

Sheehy J, Rutledge H, Acharya UR, Loh HW, Gururajan R, Tao X, et al. Gynecological cancer prognosis using machine learning techniques: a systematic review of the last three decades (1990–2022). Artif Intell Med. 2023;139: 102536.

Article  PubMed  Google Scholar 

Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cell Mol Biol Lett. 2022;27(1):21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maleki Dana P, Sadoughi F, Asemi Z, Yousefi B. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review. Cell Mol Biol Lett. 2022;27(1):1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arooj A, Rabail R, Naeem M, Goksen G, Xu B, Aadil RM. A comprehensive review of the bioactive components of sesame seeds and their impact on bone health issues in postmenopausal women. Food Funct. 2023;14(11):4966–80.

Article  CAS  PubMed  Google Scholar 

Rosalina R, Weerapreeyakul N. An insight into sesamolin: physicochemical properties, pharmacological activities, and future research prospects. Molecules. 2021;26(19):5849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Srisongkram T, Weerapreeyakul N. Route of intracellular uptake and cytotoxicity of sesamol, sesamin, and sesamolin in human melanoma SK-MEL-2 cells. Biomed Pharmacother. 2022;146: 112528.

Article  CAS  PubMed  Google Scholar 

Lin X, Zheng X, Yang B, Chen J, Xu Q, Wang Q. Clinical significance and immune landscapes of stemness-related and immune gene set-based signature in oral cancer. Clin Transl Med. 2021;11(2): e343.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Chen J, Li X, Chen D, Luo K, Deng Y, et al. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/beta-catenin signaling in hepatocellular carcinoma. Arch Toxicol. 2023;97(6):1627–47.

Article  CAS  PubMed  Google Scholar 

Miranda A, Hamilton PT, Zhang AW, Pattnaik S, Becht E, Mezheyeuski A, et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc Natl Acad Sci U S A. 2019;116(18):9020–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ronchetti L, Terrenato I, Ferretti M, Corrado G, Goeman F, Donzelli S, et al. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res. 2022;41(1):151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Liu J, Zou Y, Tao C, Chen J. Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients’ prognosis. Phytomedicine. 2022;105: 154364.

Article  CAS  PubMed  Google Scholar 

Lin X, Wang F, Chen J, Liu J, Lin YB, Li L, et al. N(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance. Mil Med Res. 2022;9(1):19.

CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Chen J, Tao C, Luo L, He J, Wang Q. Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease. MedComm (2020). 2023;4(2):e219.

CAS  PubMed  Google Scholar 

Kalogera E, Roy D, Khurana A, Mondal S, Weaver AL, He X, et al. Quinacrine in endometrial cancer: repurposing an old antimalarial drug. Gynecol Oncol. 2017;146(1):187–95.

Article  CAS  PubMed  Google Scholar 

Han P, An N, Yang L, Ren XD, Lu SL, Ji H, et al. Molecular dynamics simulation of the interactions between sesamol and myosin combined with spectroscopy and molecular docking studies. Food Hydrocoll. 2022;131:107801.

Article  CAS  Google Scholar 

Pianjing P, Thiantanawat A, Rangkadilok N, Watcharasit P, Mahidol C, Satayavivad J. Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells. J Agric Food Chem. 2011;59(1):212–21.

Article  CAS  PubMed  Google Scholar 

Sobocan M, Smolle MA, Schatz C, Haybaeck J. The interplay of tumor stroma and translational factors in endometrial cancer. Cancers (Basel). 2020;12(8):2074.

Article  CAS  PubMed  Google Scholar 

Ma X, Zhao T, Yan H, Guo K, Liu Z, Wei L, et al. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-kappaB pathway in endometrial carcinoma. Cell Death Dis. 2021;12(6):544.

Article  CAS  PubMed